CT-CHO
LIVE

Serial Number

79373612

Owner

CELLTRION, INC.

Attorney

Kisuk Lee

Filing Date

May 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CT-CHO Trademark

Serial Number: 79373612 • Registration: 7518388

CT-CHO is a trademark filed by CELLTRION, INC. on May 25, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CELLTRION, INC. (115 trademarks)

23, Academy-ro,

Entity Type: 03

Trademark Details

Filing Date

May 25, 2023

Registration Date

October 1, 2024

Published for Opposition

July 16, 2024

Goods & Services

All purpose deodorizing preparations for household, commercial or industrial use; mothproof paper; insecticides; dietary supplements; first aid boxes sold filled; food for babies; preparations of microorganisms for medical and veterinary use; medicated baby diapers; medical and surgical plasters; cell culture media for medical use; biological tissue cultures for medical purposes; cells for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparationsfor the treatment of viral diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of dermatological diseases; pharmaceutical preparations for the treatment of cancer and tumor pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of endocrine diseases; pharmaceutical preparations for the treatment of genitourinary diseases; pharmaceutical preparations for the treatment of hepatological diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of cardiovascular disease; milk sugar for medical purposes [lactose]; diagnostic preparations for medical purposes; adhesive skin patches for medical use; antibodies for medical purposes; surgical implants grown from living tissue stem cells; dental abrasives; fly glue

Reagent paper for inspection other than for medical or veterinary purposes; china clay; by-products of the processing of cereals for industrial purposes; chemicals used in industry/science and photography as well as in agriculture/ horticulture and forestry; artificial sweeteners used in industry; chemicals and adhesives used in industry; cell growth media for growing cells for use in scientific research; cells for scientific or laboratory purposes; ceramic glazings in the nature of a dry chemical preparation for use in the manufacture of ceramics; unprocessed artificial resin; antifreezing liquids; birdlime; biological preparations for use in biotechnology industry other than medical; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; hydraulic oils; metalloids; stem cells, other than for medical or veterinary purposes; chemical compositions for the manufacture of technical ceramics; chemical paper pulp

Research in relation to technology for construction purposes; architectural services; development of engineering products; scientific research; testing, inspection and research services in the fields of agriculture, livestock breeding and fisheries; development of biotechnology; drug discovery services; outsource service providers in the field of information technology relating to installation, maintenance and repair of computer software; pharmaceutical research and development; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; medical research laboratories; dress design services; analysis and evaluation of medical product development; new product design; design and development of computers and programs for computers; design, maintenance, rental and updating of computer software; development of computer hardware; marine, aerial and land surveying; cosmetic research; research in the field of environmental conservation and protection

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 1, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 1, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 28, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 13, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 12, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 13, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 13, 2024 COAR
REFUSAL PROCESSED BY IB
Feb 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 9, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2023 REPR